{"id":17350,"date":"2014-03-14T10:22:50","date_gmt":"2014-03-14T14:22:50","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=17350"},"modified":"2014-03-14T10:22:50","modified_gmt":"2014-03-14T14:22:50","slug":"depomed-inc-nasdaqdepo-prepares-for-10-million-windfall","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/depomed-inc-nasdaqdepo-prepares-for-10-million-windfall-17350","title":{"rendered":"Depomed Inc (NASDAQ:DEPO) Prepares For $10 Million Windfall"},"content":{"rendered":"<p style=\"text-align: justify;\">Boston, MA 03\/14\/2014 (wallstreetpr) &#8211;\u00a0<b>Depomed Inc (NASDAQ:DEPO)<\/b> is a specialty pharmaceutical company. The company licenses out its drug technologies and collects royalties on the same. The company is now set to receive $10 million after the U.S. Food and Drug Administration approved a drug developed by Mallinckrodt PLC using its technology. The drug is target at pain treatment.<\/p>\n<p style=\"text-align: justify;\">Depomed Inc (NASDAQ:DEPO) licensed its drug delivery technology called Acuform to Mallinckrodt, a Dublin, Ireland based pharmaceutical company with headquarters in St. Louis, U.S. The company used Acuform in its drug Xartemis that is meant as a therapy for acute pain.<\/p>\n<p style=\"text-align: justify;\">Shares of Depomed Inc (NASDAQ:DEPO) gained 10.67 percent to $14.94 in the last session. The gain came on the back a significant volume of shares changing hands. The excitement in the stock in the previous session saw the stock touching a new 52-week high at $15.39.<\/p>\n<p style=\"text-align: justify;\">According to Depomed Inc (NASDAQ:DEPO) chief executive Jim Schoeneck, they expect significant revenue from royalty payments from the sale of Mallinckrodt\u2019s drug.<\/p>\n<p style=\"text-align: justify;\"><b>Move to profits<\/b><\/p>\n<p style=\"text-align: justify;\">Following a lucrative deal with PDL BioPharma, Depomed Inc (NASDAQ:DEPO) was able to swing to profits in the fourth quarter and it hopes that they days quarters are will even be better.<\/p>\n<p style=\"text-align: justify;\">In the fourth quarter, Depomed Inc (NASDAQ:DEPO) reported $41.8 million profit or $0.72 per share. That compared with loss of $3.7 million or $0.07 per share in the corresponding quarter a year earlier. Revenue in the quarter was down 4.1 percent to $22.5 million. However, even with the slip in revenue figure year-over-year, the fourth quarter data still managed to beat estimates on both fronts. Analysts had predicted loss of $0.20 and revenue of $19.1 million.<\/p>\n<p style=\"text-align: justify;\"><b>The deal that defined performance strength<\/b><\/p>\n<p style=\"text-align: justify;\">Depomed Inc (NASDAQ:DEPO)\u2019s encouraging performance was largely due to the deal it entered in October with PDL BioPharma Inc (NASDAQ:PDLI). The deal allowed it to receive $240.5 million in cash for which it has now transferred its royalty rights of Type 2 diabetes products to PDL BioPharma Inc (NASDAQ:PDLI). The deal allows PDL BioPharma Inc (NASDAQ:PDLI) to receive royalty and milestone payment on the products until they total twice the amount of money it has given out.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Boston, MA 03\/14\/2014 (wallstreetpr) &#8211;\u00a0Depomed Inc (NASDAQ:DEPO) is a specialty pharmaceutical company. The company licenses out its drug technologies and collects royalties on the same. [&hellip;]<\/p>\n","protected":false},"author":10,"featured_media":17352,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[5200,5201,5203,5202],"stock_ticker":[],"class_list":["post-17350","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-depomed-inc-nasdaqdepo","tag-nasdaqdepo","tag-nasdaqpdli","tag-pdl-biopharma-inc-nasdaqpdli","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Depomed Inc (NASDAQ:DEPO) Prepares For $10 Million Windfall - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/depomed-inc-nasdaqdepo-prepares-for-10-million-windfall-17350\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Depomed Inc (NASDAQ:DEPO) Prepares For $10 Million Windfall - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Boston, MA 03\/14\/2014 (wallstreetpr) &#8211;\u00a0Depomed Inc (NASDAQ:DEPO) is a specialty pharmaceutical company. The company licenses out its drug technologies and collects royalties on the same. [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/depomed-inc-nasdaqdepo-prepares-for-10-million-windfall-17350\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2014-03-14T14:22:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/Depomed-Inc.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"220\" \/>\n\t<meta property=\"og:image:height\" content=\"110\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Alan Masterson\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Alan Masterson\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/depomed-inc-nasdaqdepo-prepares-for-10-million-windfall-17350#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/depomed-inc-nasdaqdepo-prepares-for-10-million-windfall-17350\"},\"author\":{\"name\":\"Alan Masterson\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e2af522c6015a6a581684f88e4c33c90\"},\"headline\":\"Depomed Inc (NASDAQ:DEPO) Prepares For $10 Million Windfall\",\"datePublished\":\"2014-03-14T14:22:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/depomed-inc-nasdaqdepo-prepares-for-10-million-windfall-17350\"},\"wordCount\":369,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/depomed-inc-nasdaqdepo-prepares-for-10-million-windfall-17350#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/Depomed-Inc.jpg\",\"keywords\":[\"Depomed Inc (NASDAQ:DEPO)\",\"NASDAQ:DEPO\",\"NASDAQ:PDLI\",\"PDL BioPharma Inc (NASDAQ:PDLI)\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/depomed-inc-nasdaqdepo-prepares-for-10-million-windfall-17350#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/depomed-inc-nasdaqdepo-prepares-for-10-million-windfall-17350\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/depomed-inc-nasdaqdepo-prepares-for-10-million-windfall-17350\",\"name\":\"Depomed Inc (NASDAQ:DEPO) Prepares For $10 Million Windfall - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/depomed-inc-nasdaqdepo-prepares-for-10-million-windfall-17350#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/depomed-inc-nasdaqdepo-prepares-for-10-million-windfall-17350#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/Depomed-Inc.jpg\",\"datePublished\":\"2014-03-14T14:22:50+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/depomed-inc-nasdaqdepo-prepares-for-10-million-windfall-17350#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/depomed-inc-nasdaqdepo-prepares-for-10-million-windfall-17350\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/depomed-inc-nasdaqdepo-prepares-for-10-million-windfall-17350#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/Depomed-Inc.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/Depomed-Inc.jpg\",\"width\":220,\"height\":110},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/depomed-inc-nasdaqdepo-prepares-for-10-million-windfall-17350#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Depomed Inc (NASDAQ:DEPO) Prepares For $10 Million Windfall\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e2af522c6015a6a581684f88e4c33c90\",\"name\":\"Alan Masterson\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/f09370963119b5d583d3dec68718fdaffc52a80c920398e0d1387fee0a33129e?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/f09370963119b5d583d3dec68718fdaffc52a80c920398e0d1387fee0a33129e?s=96&d=mm&r=g\",\"caption\":\"Alan Masterson\"},\"description\":\"Alan has over 25 years of trading experience in the U.S. equity markets. He began his career in finance working on a program trading desk specializing in over-the-counter stocks. His career progressed from that point to his current position as senior trader on an institutional trading desk. In the evenings, Alan teaches economics at a local community college. He has contributed articles to various publications over the last six years, including feature articles for an economics magazine and various financial blogs. You may contact Alan via his email (alanmasterson@cablemanpro.com) or his Google+ page (https:\/\/plus.google.com\/103338576216002376250).\",\"sameAs\":[\"https:\/\/cablemanpro.com\/wallstreetpr\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/alan-masterson\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Depomed Inc (NASDAQ:DEPO) Prepares For $10 Million Windfall - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/depomed-inc-nasdaqdepo-prepares-for-10-million-windfall-17350","og_locale":"en_US","og_type":"article","og_title":"Depomed Inc (NASDAQ:DEPO) Prepares For $10 Million Windfall - Wall Street PR","og_description":"Boston, MA 03\/14\/2014 (wallstreetpr) &#8211;\u00a0Depomed Inc (NASDAQ:DEPO) is a specialty pharmaceutical company. The company licenses out its drug technologies and collects royalties on the same. [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/depomed-inc-nasdaqdepo-prepares-for-10-million-windfall-17350","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2014-03-14T14:22:50+00:00","og_image":[{"width":220,"height":110,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/Depomed-Inc.jpg","type":"image\/jpeg"}],"author":"Alan Masterson","twitter_misc":{"Written by":"Alan Masterson","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/depomed-inc-nasdaqdepo-prepares-for-10-million-windfall-17350#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/depomed-inc-nasdaqdepo-prepares-for-10-million-windfall-17350"},"author":{"name":"Alan Masterson","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e2af522c6015a6a581684f88e4c33c90"},"headline":"Depomed Inc (NASDAQ:DEPO) Prepares For $10 Million Windfall","datePublished":"2014-03-14T14:22:50+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/depomed-inc-nasdaqdepo-prepares-for-10-million-windfall-17350"},"wordCount":369,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/depomed-inc-nasdaqdepo-prepares-for-10-million-windfall-17350#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/Depomed-Inc.jpg","keywords":["Depomed Inc (NASDAQ:DEPO)","NASDAQ:DEPO","NASDAQ:PDLI","PDL BioPharma Inc (NASDAQ:PDLI)"],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/depomed-inc-nasdaqdepo-prepares-for-10-million-windfall-17350#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/depomed-inc-nasdaqdepo-prepares-for-10-million-windfall-17350","url":"https:\/\/cablemanpro.com\/wallstreetpr\/depomed-inc-nasdaqdepo-prepares-for-10-million-windfall-17350","name":"Depomed Inc (NASDAQ:DEPO) Prepares For $10 Million Windfall - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/depomed-inc-nasdaqdepo-prepares-for-10-million-windfall-17350#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/depomed-inc-nasdaqdepo-prepares-for-10-million-windfall-17350#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/Depomed-Inc.jpg","datePublished":"2014-03-14T14:22:50+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/depomed-inc-nasdaqdepo-prepares-for-10-million-windfall-17350#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/depomed-inc-nasdaqdepo-prepares-for-10-million-windfall-17350"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/depomed-inc-nasdaqdepo-prepares-for-10-million-windfall-17350#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/Depomed-Inc.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/Depomed-Inc.jpg","width":220,"height":110},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/depomed-inc-nasdaqdepo-prepares-for-10-million-windfall-17350#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Depomed Inc (NASDAQ:DEPO) Prepares For $10 Million Windfall"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e2af522c6015a6a581684f88e4c33c90","name":"Alan Masterson","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/f09370963119b5d583d3dec68718fdaffc52a80c920398e0d1387fee0a33129e?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f09370963119b5d583d3dec68718fdaffc52a80c920398e0d1387fee0a33129e?s=96&d=mm&r=g","caption":"Alan Masterson"},"description":"Alan has over 25 years of trading experience in the U.S. equity markets. He began his career in finance working on a program trading desk specializing in over-the-counter stocks. His career progressed from that point to his current position as senior trader on an institutional trading desk. In the evenings, Alan teaches economics at a local community college. He has contributed articles to various publications over the last six years, including feature articles for an economics magazine and various financial blogs. You may contact Alan via his email (alanmasterson@cablemanpro.com) or his Google+ page (https:\/\/plus.google.com\/103338576216002376250).","sameAs":["https:\/\/cablemanpro.com\/wallstreetpr"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/alan-masterson"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/17350","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=17350"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/17350\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/17352"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=17350"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=17350"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=17350"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=17350"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}